These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31780314)
1. Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus. Pannu N; Bhatnagar A Immunobiology; 2020 Jan; 225(1):151871. PubMed ID: 31780314 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic effect of resveratrol and piperine on pristane-induced murine model of lupus-like disease. Pannu N; Bhatnagar A Inflammopharmacology; 2020 Jun; 28(3):719-735. PubMed ID: 32415428 [TBL] [Abstract][Full Text] [Related]
3. Combinatorial therapeutic effect of resveratrol and piperine on murine model of systemic lupus erythematosus. Pannu N; Bhatnagar A Inflammopharmacology; 2020 Apr; 28(2):401-424. PubMed ID: 31732838 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis. Dos Santos M; Poletti PT; Favero G; Stacchiotti A; Bonomini F; Montanari CC; Bona SR; Marroni NP; Rezzani R; Veronese FV Autoimmunity; 2018 Mar; 51(2):69-80. PubMed ID: 29480020 [TBL] [Abstract][Full Text] [Related]
5. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model. Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735 [TBL] [Abstract][Full Text] [Related]
6. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432 [TBL] [Abstract][Full Text] [Related]
7. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clynes R; Calvani N; Croker BP; Richards HB Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509 [TBL] [Abstract][Full Text] [Related]
9. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus. Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427 [TBL] [Abstract][Full Text] [Related]
10. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Satoh M; Kumar A; Kanwar YS; Reeves WH Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10934-8. PubMed ID: 7479913 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function. Song X; Gao J; Liu H; Liu X; Tang K Biomed Pharmacother; 2021 May; 137():111289. PubMed ID: 33581650 [TBL] [Abstract][Full Text] [Related]
13. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Chowdhary VR; Grande JP; Luthra HS; David CS Rheumatology (Oxford); 2007 Sep; 46(9):1405-10. PubMed ID: 17576695 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model. Correa Freitas E; Evelyn Karnopp T; de Souza Silva JM; Cavalheiro do Espírito Santo R; da Rosa TH; de Oliveira MS; da Costa Gonçalves F; de Oliveira FH; Guilherme Schaefer P; André Monticielo O Autoimmunity; 2019 Mar; 52(2):69-77. PubMed ID: 31088305 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347 [TBL] [Abstract][Full Text] [Related]
16. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice. Liu X; Jiao Y; Cui B; Gao X; Xu J; Zhao Y Lupus; 2016 Oct; 25(11):1180-9. PubMed ID: 27125291 [TBL] [Abstract][Full Text] [Related]
17. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus. Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258 [TBL] [Abstract][Full Text] [Related]
18. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus. Wang H; Knight JS; Hodgin JB; Wang J; Guo C; Kleiman K; Eitzman DT Sci Rep; 2016 Jun; 6():28997. PubMed ID: 27357136 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434 [TBL] [Abstract][Full Text] [Related]
20. Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model. Khorasani S; Mahmoudi M; Kalantari MR; Lavi Arab F; Esmaeili SA; Mardani F; Tabasi N; Rastin M J Cell Physiol; 2019 Jun; 234(6):9778-9786. PubMed ID: 30370554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]